Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.75 |
| ▸ | SRC | P12931 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | CES1 | P23141 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mandelic Acid SCHEMBL9747772 | 1.00 | LMNA (0.75) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL388417 | 0.98 | LMNA (0.72) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL5313046 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL29777368 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL21647917 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL255601 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL165161 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL1050 | 0.87 | LMNA (1.00) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL29214389 | 0.85 | LMNA (0.86) | LMNAMAPK1SRCCES2CES1 | |
| Mandelic Acid SCHEMBL3622024 | 0.85 | LMNA (0.86) | LMNAMAPK1SRCCES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4530 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724049-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | Catalent Ontario Limited (CA) | 2026-04-15 | — | — | EP | claimed |
| CN-119548497-A | Method for treating myopia by using vinpocetine | 温州医科大学附属眼视光医院 | 2025-03-04 | — | — | CN | claimed |
| EP-3197459-B1 | POLYMERIC BILE ACID DERIVATIVES INHIBIT HEPATITIS B AND D VIRUS AND NTCP TRANSPORT | HUAHUI HEALTH LTD (CN) | 2025-02-12 | — | — | EP | claimed |
| WO-2024254056-A1 | MODIFIED RELEASE FILL COMPOSITIONS FOR DOSAGE FORMS AND METHODS OF PREPARATION AND USE THEREOF | CATALENT ONTARIO LIMITED (CA) | 2024-12-12 | — | — | WO | claimed |
| CN-118634218-A | Pharmaceutical composition for effectively delaying and treating myopia | 温州医科大学附属眼视光医院 | 2024-09-13 | — | — | CN | claimed |
| US-20220169680-A1 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | INSTITUTE OF BASIC MEDICAL SCIENCES CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2022-06-02 | — | — | US | claimed |
| EP-3965771-A1 | FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH AS METHENAMINE MANDELATE | Edenbridge Pharmaceuticals, LLC (US) | 2022-03-16 | — | — | EP | claimed |
| EP-3912989-A1 | CELL-PENETRATING PEPTIDE BASED ON INFLUENZA VIRUS M2 PROTEIN | Institute of Basic Medical Sciences Chinese Academy of Medical Sciences (CN) | 2021-11-24 | — | — | EP | claimed |
| US-20210322424-A1 | Finished Pharmaceutical Dosage Form Of A Methenamine Salt Such As Methenamine Mandelate | Edenbridge Pharmaceuticals, LLC (US) | 2021-10-21 | — | — | US | claimed |
| WO-2021112914-A1 | FINISHED PHARMACEUTICAL DOSAGE FORM OF A METHENAMINE SALT SUCH AS METHENAMINE MANDELATE | Edenbridge Pharmaceuticals, LLC (US) | 2021-06-10 | — | — | WO | claimed |
| EP-0436664-A1 | CLEAVABLE LINKERS FOR THE REDUCTION OF NON-TARGET ORGAN RETENTION OF IMMUNOCONJUGATES. | NEORX CORP (US) | 1991-07-17 | — | — | EP | claimed |
| US-4952402-A | EDIBLE TASTE-MASKED DRUGS; MICROMATRIX ACTIVE MATERIAL COATED WITH NONTOXIC POLYMER; LIQUIDS; TABLETS | ELAN CORPORATION, P.L.C. (IE) | 1990-08-28 | — | — | US | claimed |
| EP-0303545-A2 | Process for the preparation of phenylethanolaminotetralines | ELF SANOFI (FR) | 1989-02-15 | — | — | EP | claimed |
| US-4601880-A | POLYMER, FORMALDEHYDE RELEASING COMPOUND | ALZA CORPORATION (US) | 1986-07-22 | — | — | US | claimed |
| US-4464258-A | METHENAMINE | ALZA CORPORATION (US) | 1984-08-07 | — | — | US | claimed |
| US-4369172-A | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | FOREST LABORATORIES INC. (US) | 1983-01-18 | — | — | US | claimed |
| US-4288543-A | SAMPLING IN LIQUID PHASE WITH ANTIGROWTH AGENTS-BIOLOGICAL | PFIZER INC. (US) | 1981-09-08 | — | — | US | claimed |
| US-4241195-A | COATING OF FORMAMIDINESULFINIC ACID, METHENAMINE MANDELATE, IN RESINOUS CARRIER | WESTINGHOUSE ELECTRIC CORP. (US) | 1980-12-23 | — | — | US | claimed |
| US-4149161-A | Protecting electrical apparatus with gas generating compounds | WESTINGHOUSE ELECTRIC CORP. (US) | 1979-04-10 | — | — | US | claimed |
| US-4126468-A | Radiation sensitive compositions of quaternary ammonium salt and carboxylic acid sensitizer | VICKERS LIMITED (GB) | 1978-11-21 | — | — | US | claimed |